2Sauriasari R,Andrajati R,Azizahwati,et al.Marker of lipid peroxidation related to diabetic nephropathy in Indonesian typediabetes mellitus patients[J].Diabetes Res Clin Pract,2015,108(1):193-200.
3Jheng HF,Tsai PJ,Chuang YL,et al.Albumin stimulates renal tubular inflammation through an HSP70-TLR4axis in mice with early diabetic nephropathy[J].Dis Model Mech,2015,8(10):1311-1321.
4Elsherbiny NM,Al-Gayyar MM,Abd El Galil KH.Nephroprotective role of dipyridamole in diabetic nephropathy:Effect on inflammation and apoptosis[J].Life Sci,2015,15(143):8-17.
5Bouvet BR,Paparella CV,Arriaga SM,et al.Evaluation of urinary N-acetyl-beta-D-glucosaminidase as a marker of early renal damage in patients with type 2diabetes mellitus[J].Arq Bras Endocrinol Metabol,2014,58(8):798-801.
6Ouchi M,Oba K,Motoyama M,et al.Postprandial glycemic control conditions in relation to urinary N-acetyl-β-D-glucosaminidase in patients with type 2diabetes mellitus without low glomerular filtration rate[J].Diabetes Technol Ther,2014,16(1):41-47.
7Murakoshi M,Tanimoto M,Gohda T,et al.Mindin:a novel marker for podocyte injury in diabetic nephropathy[J].Nephrol Dial Transplant,2011,26(7):2153-2160.
8Mao S,Xiang W,Huang S,et al.Association between homocysteine status and the risk of nephropathy in type 2diabetes mellitus[J].Clin Chim Acta,2014,20(431):206-210.
9Wang H,Cui K,Xu K,et al.Association between plasma homocysteine and progression of early nephropathy in type 2diabetic patients[J].Int J Clin Exp Med,2015,8(7):11174-11180.
10Asefy Z,Mirinejad M,Amirrasooli H,et al.Assessing validity of serum cystatin C for predicting metabolic syndrome[J].Pak J Biol Sci,2014,17(4):582-585.
